
Chinese General Practice ›› 2022, Vol. 25 ›› Issue (23): 2885-2891.DOI: 10.12114/j.issn.1007-9572.2022.0246
Special Issue: 泌尿系统疾病最新文章合辑; 肾脏疾病最新文章合辑; 神经系统疾病最新文章合辑; 脑健康最新研究合辑
• Article • Previous Articles Next Articles
Received:2022-02-08
Revised:2022-04-20
Published:2022-08-15
Online:2022-04-22
Contact:
Meiqi YAO
About author:
通讯作者:
姚梅琪
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0246
| 项目 | AKI亚组(n=140) | 非AKI亚组(n=620) | χ2(Z)值 | P值 | 项目 | AKI亚组(n=140) | 非AKI亚组(n=620) | χ2(Z)值 | P值 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 性别 | 8.858 | 0.003 | 抗凝药用药史 | 11.108 | 0.001 | ||||||
| 男 | 106(75.7) | 387(62.4) | 有 | 50(35.7) | 138(22.3) | ||||||
| 女 | 34(24.3) | 233(37.6) | 无 | 90(64.3) | 482(77.7) | ||||||
| 年龄(岁) | 2.761 | 0.097 | 袢利尿剂用药史 | 38.575 | <0.001 | ||||||
| ≥65 | 90(64.3) | 351(56.6) | 有 | 27(19.3) | 27(4.4) | ||||||
| <65 | 50(35.7) | 269(43.4) | 无 | 113(80.7) | 593(95.6) | ||||||
| 脑卒中类型 | 0.455 | 0.500 | 抗生素用药史 | 12.126 | <0.001 | ||||||
| 脑出血 | 12(8.6) | 43(6.9) | 有 | 42(30.0) | 106(17.1) | ||||||
| 脑梗死 | 128(91.4) | 577(93.1) | 无 | 98(70.0) | 514(82.9) | ||||||
| 复发史 | 溶栓史 | 2.767 | 0.096 | ||||||||
| 有 | 29(20.7) | 80(12.9) | 5.672 | 0.017 | 有 | 29(20.7) | 93(15.5) | ||||
| 无 | 111(79.3) | 540(87.1) | 无 | 111(79.3) | 527(84.5) | ||||||
| 高血压史 | 机械取栓史 | 16.020 | <0.001 | ||||||||
| 有 | 115(82.1) | 403(65.0) | 15.465 | <0.001 | 有 | 25(17.9) | 44(7.1) | ||||
| 无 | 25(17.9) | 217(35.0) | 无 | 115(82.1) | 576(92.9) | ||||||
| 糖尿病史 | 1.589 | 0.208 | hs-CRP | 28.846 | <0.001 | ||||||
| 有 | 52(37.1) | 196(31.6) | 升高 | 77(55.0) | 192(31.0) | ||||||
| 无 | 88(62.9) | 424(68.4) | 正常 | 63(45.0) | 428(69.0) | ||||||
| 冠心病史 | 11.515 | 0.001 | NGAL | 22.172 | <0.001 | ||||||
| 有 | 19(13.6) | 34(5.5) | 升高 | 28(20.0) | 44(7.1) | ||||||
| 无 | 121(86.4) | 586(94.5) | 正常 | 112(80.0) | 576(92.9) | ||||||
| 心房颤动史 | 18.696 | <0.001 | Hcy | 50.564 | <0.001 | ||||||
| 有 | 43(30.7) | 94(15.2) | 升高 | 101(72.1) | 242(39.0) | ||||||
| 无 | 97(69.3) | 526(84.8) | 正常 | 39(27.9) | 378(61.0) | ||||||
| 贫血 | 25.412 | <0.001 | β2-MG | 226.617 | <0.001 | ||||||
| 是 | 42(30.0) | 79(12.7) | 升高 | 80(57.1) | 38(6.1) | ||||||
| 否 | 98(70.0) | 541(87.3) | 正常 | 60(42.9) | 582(93.9) | ||||||
| NIHSS评分(分) | -3.668a | <0.001 | 尿素氮 | 110.322 | <0.001 | ||||||
| ≤8 | 92(65.7) | 494(79.7) | 升高 | 64(45.7) | 59(9.5) | ||||||
| 9~14 | 23(16.4) | 71(11.4) | 正常 | 76(54.3) | 561(90.5) | ||||||
| ≥15 | 25(17.9) | 55(8.9) | 血尿酸 | 63.521 | <0.001 | ||||||
| 甘露醇用药史 | 8.826 | 0.003 | 升高 | 52(37.1) | 64(10.3) | ||||||
| 有 | 28(20.0) | 67(10.8) | 正常 | 88(62.9) | 556(89.7) | ||||||
| 无 | 112(80.0) | 553(89.2) | sCysC | 267.219 | <0.001 | ||||||
| 抗血小板药用药史 | 18.710 | <0.001 | 升高 | 87(62.1) | 36(5.8) | ||||||
| 有 | 91(65.0) | 506(81.6) | 正常 | 53(37.9) | 584(94.2) | ||||||
| 无 | 49(35.0) | 114(18.4) | |||||||||
Table 1 Univariate regression analysis of factors associated with acute kidney injury in patients with stroke
| 项目 | AKI亚组(n=140) | 非AKI亚组(n=620) | χ2(Z)值 | P值 | 项目 | AKI亚组(n=140) | 非AKI亚组(n=620) | χ2(Z)值 | P值 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 性别 | 8.858 | 0.003 | 抗凝药用药史 | 11.108 | 0.001 | ||||||
| 男 | 106(75.7) | 387(62.4) | 有 | 50(35.7) | 138(22.3) | ||||||
| 女 | 34(24.3) | 233(37.6) | 无 | 90(64.3) | 482(77.7) | ||||||
| 年龄(岁) | 2.761 | 0.097 | 袢利尿剂用药史 | 38.575 | <0.001 | ||||||
| ≥65 | 90(64.3) | 351(56.6) | 有 | 27(19.3) | 27(4.4) | ||||||
| <65 | 50(35.7) | 269(43.4) | 无 | 113(80.7) | 593(95.6) | ||||||
| 脑卒中类型 | 0.455 | 0.500 | 抗生素用药史 | 12.126 | <0.001 | ||||||
| 脑出血 | 12(8.6) | 43(6.9) | 有 | 42(30.0) | 106(17.1) | ||||||
| 脑梗死 | 128(91.4) | 577(93.1) | 无 | 98(70.0) | 514(82.9) | ||||||
| 复发史 | 溶栓史 | 2.767 | 0.096 | ||||||||
| 有 | 29(20.7) | 80(12.9) | 5.672 | 0.017 | 有 | 29(20.7) | 93(15.5) | ||||
| 无 | 111(79.3) | 540(87.1) | 无 | 111(79.3) | 527(84.5) | ||||||
| 高血压史 | 机械取栓史 | 16.020 | <0.001 | ||||||||
| 有 | 115(82.1) | 403(65.0) | 15.465 | <0.001 | 有 | 25(17.9) | 44(7.1) | ||||
| 无 | 25(17.9) | 217(35.0) | 无 | 115(82.1) | 576(92.9) | ||||||
| 糖尿病史 | 1.589 | 0.208 | hs-CRP | 28.846 | <0.001 | ||||||
| 有 | 52(37.1) | 196(31.6) | 升高 | 77(55.0) | 192(31.0) | ||||||
| 无 | 88(62.9) | 424(68.4) | 正常 | 63(45.0) | 428(69.0) | ||||||
| 冠心病史 | 11.515 | 0.001 | NGAL | 22.172 | <0.001 | ||||||
| 有 | 19(13.6) | 34(5.5) | 升高 | 28(20.0) | 44(7.1) | ||||||
| 无 | 121(86.4) | 586(94.5) | 正常 | 112(80.0) | 576(92.9) | ||||||
| 心房颤动史 | 18.696 | <0.001 | Hcy | 50.564 | <0.001 | ||||||
| 有 | 43(30.7) | 94(15.2) | 升高 | 101(72.1) | 242(39.0) | ||||||
| 无 | 97(69.3) | 526(84.8) | 正常 | 39(27.9) | 378(61.0) | ||||||
| 贫血 | 25.412 | <0.001 | β2-MG | 226.617 | <0.001 | ||||||
| 是 | 42(30.0) | 79(12.7) | 升高 | 80(57.1) | 38(6.1) | ||||||
| 否 | 98(70.0) | 541(87.3) | 正常 | 60(42.9) | 582(93.9) | ||||||
| NIHSS评分(分) | -3.668a | <0.001 | 尿素氮 | 110.322 | <0.001 | ||||||
| ≤8 | 92(65.7) | 494(79.7) | 升高 | 64(45.7) | 59(9.5) | ||||||
| 9~14 | 23(16.4) | 71(11.4) | 正常 | 76(54.3) | 561(90.5) | ||||||
| ≥15 | 25(17.9) | 55(8.9) | 血尿酸 | 63.521 | <0.001 | ||||||
| 甘露醇用药史 | 8.826 | 0.003 | 升高 | 52(37.1) | 64(10.3) | ||||||
| 有 | 28(20.0) | 67(10.8) | 正常 | 88(62.9) | 556(89.7) | ||||||
| 无 | 112(80.0) | 553(89.2) | sCysC | 267.219 | <0.001 | ||||||
| 抗血小板药用药史 | 18.710 | <0.001 | 升高 | 87(62.1) | 36(5.8) | ||||||
| 有 | 91(65.0) | 506(81.6) | 正常 | 53(37.9) | 584(94.2) | ||||||
| 无 | 49(35.0) | 114(18.4) | |||||||||
| 自变量 | 赋值 | 自变量 | 赋值 |
|---|---|---|---|
| 性别 | 女=0,男=1 | 袢利尿剂用药史 | 无=0,有=1 |
| 复发史 | 无=0,有=1 | 抗生素用药史 | 无=0,有=1 |
| 高血压史 | 无=0,有=1 | 机械取栓史 | 无=0,有=1 |
| 冠心病史 | 无=0,有=1 | hs-CRP | 正常=0,升高=1 |
| 心房颤动史 | 无=0,有=1 | NGAL | 正常=0,升高=1 |
| 贫血 | 否=0,是=1 | Hcy | 正常=0,升高=1 |
| NIHSS评分 | <15分=0,≥15分=1 | β2-MG | 正常=0,升高=1 |
| 甘露醇用药史 | 无=0,有=1 | 尿素氮 | 正常=0,升高=1 |
| 抗血小板药用药史 | 无=0,有=1 | 血尿酸 | 正常=0,升高=1 |
| 抗凝药用药史 | 无=0,有=1 | sCysC | 正常=0,升高=1 |
Table 2 Assignment for factors associated with post-stroke acute kidney injury analyzed using multivariate Logistic regression
| 自变量 | 赋值 | 自变量 | 赋值 |
|---|---|---|---|
| 性别 | 女=0,男=1 | 袢利尿剂用药史 | 无=0,有=1 |
| 复发史 | 无=0,有=1 | 抗生素用药史 | 无=0,有=1 |
| 高血压史 | 无=0,有=1 | 机械取栓史 | 无=0,有=1 |
| 冠心病史 | 无=0,有=1 | hs-CRP | 正常=0,升高=1 |
| 心房颤动史 | 无=0,有=1 | NGAL | 正常=0,升高=1 |
| 贫血 | 否=0,是=1 | Hcy | 正常=0,升高=1 |
| NIHSS评分 | <15分=0,≥15分=1 | β2-MG | 正常=0,升高=1 |
| 甘露醇用药史 | 无=0,有=1 | 尿素氮 | 正常=0,升高=1 |
| 抗血小板药用药史 | 无=0,有=1 | 血尿酸 | 正常=0,升高=1 |
| 抗凝药用药史 | 无=0,有=1 | sCysC | 正常=0,升高=1 |
| 变量 | 偏回归系数 | 标准误 | Wald χ2值 | P值 | OR值 | 95%CI |
|---|---|---|---|---|---|---|
| 性别 | 1.222 | 0.324 | 14.195 | <0.001 | 3.390 | (1.799,6.410) |
| 高血压史 | 1.386 | 0.337 | 16.908 | <0.001 | 4.000 | (2.066,7.747) |
| NIHSS评分 | 1.716 | 0.331 | 26.919 | <0.001 | 5.562 | (2.909,10.637) |
| 袢利尿剂用药史 | 1.098 | 0.439 | 6.259 | 0.012 | 2.999 | (1.268,7.089) |
| 机械取栓史 | 0.830 | 0.389 | 4.558 | 0.033 | 2.293 | (1.070,4.911) |
| β2-MG | 1.739 | 0.369 | 22.196 | <0.001 | 5.689 | (2.760,11.726) |
| 尿素氮 | 1.202 | 0.318 | 14.311 | <0.001 | 3.328 | (1.785,6.204) |
| sCysC | 2.160 | 0.363 | 35.476 | <0.001 | 8.674 | (4.261,17.659) |
Table 3 Multivariate Logistic regression analysis of factors associated with post-stroke acute kidney injury
| 变量 | 偏回归系数 | 标准误 | Wald χ2值 | P值 | OR值 | 95%CI |
|---|---|---|---|---|---|---|
| 性别 | 1.222 | 0.324 | 14.195 | <0.001 | 3.390 | (1.799,6.410) |
| 高血压史 | 1.386 | 0.337 | 16.908 | <0.001 | 4.000 | (2.066,7.747) |
| NIHSS评分 | 1.716 | 0.331 | 26.919 | <0.001 | 5.562 | (2.909,10.637) |
| 袢利尿剂用药史 | 1.098 | 0.439 | 6.259 | 0.012 | 2.999 | (1.268,7.089) |
| 机械取栓史 | 0.830 | 0.389 | 4.558 | 0.033 | 2.293 | (1.070,4.911) |
| β2-MG | 1.739 | 0.369 | 22.196 | <0.001 | 5.689 | (2.760,11.726) |
| 尿素氮 | 1.202 | 0.318 | 14.311 | <0.001 | 3.328 | (1.785,6.204) |
| sCysC | 2.160 | 0.363 | 35.476 | <0.001 | 8.674 | (4.261,17.659) |
| 条目 | 赋值 |
|---|---|
| 性别 | 女=0分,男=1分 |
| 高血压史 | 无=0分,有=1分 |
| NIHSS评分 | <15分=0分,≥15分=2分 |
| 袢利尿剂用药史 | 无=0分,有=1分 |
| 机械取栓史 | 无=0分,有=1分 |
| β2-MG | 正常=0分,升高=2分 |
| 尿素氮 | 正常=0分,升高=1分 |
| sCysC | 正常=0分,升高=2分 |
Table 4 The Simplified Post-stroke Acute Kidney Injury Risk Prediction Scale
| 条目 | 赋值 |
|---|---|
| 性别 | 女=0分,男=1分 |
| 高血压史 | 无=0分,有=1分 |
| NIHSS评分 | <15分=0分,≥15分=2分 |
| 袢利尿剂用药史 | 无=0分,有=1分 |
| 机械取栓史 | 无=0分,有=1分 |
| β2-MG | 正常=0分,升高=2分 |
| 尿素氮 | 正常=0分,升高=1分 |
| sCysC | 正常=0分,升高=2分 |
| [1] |
|
| [2] |
颜伟健,胡杨青,卢琳,等. 急性脑血管疾病并发急性肾损伤相关因素的分析[J]. 湖南师范大学学报:医学版,2013(3):68-70,74.
|
| [3] |
王睿,水华,胡洪涛,等. 脑出血患者发生急性肾损伤的危险因素及预后分析[J]. 临床肾脏病杂志,2018,18(10):624-629. DOI:10.3969/j.issn.1671-2390.2018.10.008.
|
| [4] |
池锐彬,邹启明,李超锋,等. 血清胱抑素C预测脑出血患者急性肾损伤及预后的临床价值[J]. 海南医学,2020,31(1):10-13. DOI:10.3969/j.issn.1003-6350.2020.01.003.
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
公方晓,杨向红. 关注肾恢复——再谈做好急性肾损伤的防治策略[J]. 医学研究生学报,2020,33(1):1-6. DOI:10.16571/j.cnki.1008-8199.2020.01.001.
|
| [9] |
|
| [10] |
|
| [11] |
各类脑血管疾病诊断要点[J]. 中华神经科杂志,1996,29(6):379-380.
|
| [12] |
|
| [13] |
肖顺贞. 临床科研设计[M]. 北京:北京大学医学出版社,2003.
|
| [14] |
肖静怡,谢小华,潘璐,等. 急性缺血性脑卒中早期神经功能恶化风险预测模型的构建[J]. 护理研究,2020,34(19):3408-3412. DOI:10.12102/j.issn.1009-6493.2020.19.006.
|
| [15] |
池锐锋,林冰薇,林喜春. 清蛋白、胱抑素C及胆红素联合检测在急性脑梗死合并急性肾损伤中的预测价值[J]. 中国当代医药,2020,27(8):48-50,55. DOI:10.3969/j.issn.1674-4721.2020.08.015.
|
| [16] |
雷莹. 中国危重症住院患者急性肾损伤发生率、院内预后及相关危险因素分析[D]. 广州:南方医科大学,2016.
|
| [17] |
|
| [18] |
林海龙. 合并蛋白尿的高血压患者需慎用利尿剂吗? [J]. 中华高血压杂志,2019,27(2):106-110. DOI:10.16439/j.cnki.1673-7245.2019.02.006.
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [1] | FENG Yuxi, WANG Jinjin, CAI Yi, ZHU Runzhi, ZHU Qin. Research Progress on Protein Lactylation in Kidney Diseases [J]. Chinese General Practice, 2026, 29(21): 3056-3063. |
| [2] | LI Jiawei, GAO Xinyi, GE Aoqi, LI Juanjuan, YUAN Beibei. Demand and Associated Factors for Integrated Medical Care and Preventive Services among Patients with Type 2 Diabetes [J]. Chinese General Practice, 2026, 29(21): 3028-3039. |
| [3] | LI Feng, HU Changhao, LUO Xu. Progress in the Study of Influencing Factors and Intervention Strategies of Mental Health in Elderly Patients with Multiple Chronic Conditions [J]. Chinese General Practice, 2026, 29(20): 2816-2828. |
| [4] | YANG Xiaofeng, LI Xianwen, WU Yanfeng, ZHANG Qian, CHEN Juan, ZHAO Fengjiao. Association of Serum Vascular Endothelial Cadherin Levels with the Risk of Post-stroke Cognitive Impairment in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(20): 2867-2873. |
| [5] | LIU Ying, LIU Shiwei, ZHANG Chi, SHEN Ji, ZHANG Yushan, ZHANG Jie, SANG Yingchen, WANG Youjiao, WANG Lei, ZHOU Houguang, SHI Hong. Prevalence and Associated Factors of Subjective Cognitive Decline among Older Stroke Patients in China [J]. Chinese General Practice, 2026, 29(20): 2829-2835. |
| [6] | ZHANG Huifang, CHEN Cunchuan, FAN Boyang, SUN Wenning, WANG Yingjie, ZHANG Ao, ZHAO Yang, WANG Haipeng. Study on the Service Capability of Primary Care Doctors to Integrate Medical and Preventive Services and Its Influencing Factors in Shandong Province [J]. Chinese General Practice, 2026, 29(19): 2711-2716. |
| [7] | CHEN Xinyi, HUANG Ziqian, CHEN Yufeng, HUANG Jun, WENG Fan, LAI Zhisheng, XUE Yumei, CAO Xi. Diagnostic Performance of a Hand-held Single-lead ECG Device in Detecting Atrial Fibrillation and Its Potential in Atrial Fibrillation Screening in Community [J]. Chinese General Practice, 2026, 29(19): 2717-2723. |
| [8] | TANG Lijuan, QI Qi, ZHANG Fan, GAO Yifu, CAO Yajing, YUE Fujuan, GAO Jinchai, LIU Xiaoli. Characterisation of the Prevalence of Overweight/Obesity among Residents Aged 18-44 Years in Hebei Province in 2013 and 2020 [J]. Chinese General Practice, 2026, 29(19): 2695-2704. |
| [9] | LIU Fang, LIU Weinan, XIANG Yuanyue, LU Cheng, ZHU Binhai. Factors Influencing Work-related Flow among "3+2" Order-oriented Assistant General Practitioners in Jiangsu Province [J]. Chinese General Practice, 2026, 29(18): 2454-2460. |
| [10] | FAN Meixiang, YAN Yunyun, HUANG Yanyan. Interpretation and Discussion of Guidelines for Preventive Activities in General Practice: Bladder Cancer [J]. Chinese General Practice, 2026, 29(18): 2450-2453. |
| [11] | WU Ruining, ZHOU Ming, ZHANG Gongzi, LI Jun, XIE Suhang, LIU Yangxiaoxue, ZHANG Jiali, LIU Maomao, HUANG Liping. Study on Fixed and Mobile Exoskeleton Robots in Improving Lower Limb Function and Quality of Life in Stroke Patients: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(17): 2326-2333. |
| [12] | CHEN Yan, SHEN Dequan, SHENG Renlei, CHANG Yujie, YANG Jiaqi, DING Jie, SUN Zhifang, WANG Dahui. Influencing Factors and Importance Ranking of the Utilization of Primary-level Traditional Chinese Medicine Preventive and Health Care Services for the Elderly [J]. Chinese General Practice, 2026, 29(16): 2182-2189. |
| [13] | LUO Yutong, LI Jing. The HPV Vaccine Coverage and Its Influencing Factors among the Eligible Population in China Based on a Geographically Weighted Regression Model [J]. Chinese General Practice, 2026, 29(16): 2234-2243. |
| [14] | FU Mingyuan, YU Xiaoyi, GE Caiying, KONG Min. Impaired Awareness of Hypoglycemia: Prevalence and Determinants among Community-based Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(16): 2252-2258. |
| [15] | CHEN Bihua, LIN Qiyi, LI Wuhua, SU Jin, TU Liping, SHI Lan, DING Xiaoqin, YI Chuntao. The Influencing Factors and Mechanisms of the Work Output Level of Family Doctor Teams from the Perspective of Team Effectiveness [J]. Chinese General Practice, 2026, 29(16): 2167-2173. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||